Cargando…

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism

BACKGROUND: A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, ‘Stopping over-medication of people with a learning disability [intellectua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deb, Shoumitro, Nancarrow, Tom, Limbu, Bharati, Sheehan, Rory, Wilcock, Mike, Branford, David, Courtenay, Ken, Perera, Bhathika, Shankar, Rohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576649/ https://www.ncbi.nlm.nih.gov/pubmed/32938512 http://dx.doi.org/10.1192/bjo.2020.97

Ejemplares similares

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021)

Support staff liaising effectively with professionals for the rational use of psychotropics for behaviours that challenge in adults with intellectual disabilities: Findings from a co-design event
por: Limbu, Bharati, et al.
Publicado: (2022)

Association between epilepsy and challenging behaviour in adults with intellectual disabilities: systematic review and meta-analysis
por: Deb, Shoumitro, et al.
Publicado: (2020)

General practitioners’ and psychiatrists’ attitudes towards antidepressant withdrawal
por: McCabe, Joanne, et al.
Publicado: (2020)

Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities (SPECTROM): study protocol
por: Deb, Shoumitro, et al.
Publicado: (2020)

Association between epilepsy and psychiatric disorders in adults with intellectual disabilities: systematic review and meta-analysis
por: Akrout Brizard, Basma, et al.
Publicado: (2021)

Causes of and Alternatives to Medication for Behaviours That Challenge in People with Intellectual Disabilities: Direct Care Providers’ Perspectives
por: Deb, Shoumitro (Shoumi), et al.
Publicado: (2022)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

Support staff liaising effectively with family caregivers: Findings from a co-design event and recommendation for a staff training resource
por: Deb, Shoumitro, et al.
Publicado: (2022)

Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing
por: Deb, Shoumitro (Shoumi), et al.
Publicado: (2021)

Comprehensive Assessment of Triggers for Behaviours of Concern Scale (CATS): Initial Development
por: Limbu, Bharati, et al.
Publicado: (2021)

Are we training psychiatrists to develop skills in intellectual disability psychiatry? Current European context and future directions
por: Casanova Dias, Marisa, et al.
Publicado: (2020)

Sleep: the neglected life factor in adults with intellectual disabilities
por: Korb, Laura, et al.
Publicado: (2023)

Attention-deficit hyperactivity disorder in people with intellectual disability: statistical approach to developing a bespoke screening tool
por: Sawhney, Indermeet, et al.
Publicado: (2021)

Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis
por: Limbu, Bharati, et al.
Publicado: (2022)

The effectiveness of parent training for children with autism spectrum disorder: a systematic review and meta-analyses
por: Deb, Shoumitro (Shoumi), et al.
Publicado: (2020)

COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive study
por: Perera, Bhathika, et al.
Publicado: (2020)

Antipsychotic prescribing of consultant forensic psychiatrists working in different levels of secure care with patients with schizophrenia
por: Machin, Anna, et al.
Publicado: (2017)

Randomised controlled trials of antidepressant and anti-anxiety medications for people with autism spectrum disorder: systematic review and meta-analysis
por: Deb, Shoumitro, et al.
Publicado: (2021)

Consultant psychiatrists’ experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study
por: Shepherd, Andrew, et al.
Publicado: (2014)

Cardiovascular risk quantification using QRISK-3 score in people with intellectual disability
por: Ho, Jamie Sin Ying, et al.
Publicado: (2021)

System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents
por: Murphy, Andrea L, et al.
Publicado: (2015)

Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study
por: Sheehan, Rory, et al.
Publicado: (2017)

ADHD and Intellectual Disability: using ADHD medication
por: Courtenay, K., et al.
Publicado: (2022)

Intellectual disability and antipsychotics
por: Iñiguez, I. Cuevas, et al.
Publicado: (2021)

Intellectual disability and Aboriginal Australians – training needs for psychiatrists
por: Roy, Meera, et al.
Publicado: (2011)

COVID-19 and people with intellectual disability: impacts of a pandemic
por: Courtenay, K., et al.
Publicado: (2020)

Benzodiazepine prescribing in tunisia: A study about psychiatrists prescribing habits
por: Lagha, M., et al.
Publicado: (2021)

Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
por: Sheehan, Rory, et al.
Publicado: (2015)

“Antipsychotics Basket of the last decade for a psychiatrist: Within and Beyond!”
Publicado: (2022)

518 Prescribing practices of atypical antipsychotics in the burn ICU
por: Gayed, Rita, et al.
Publicado: (2022)

Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey
por: Keenan, Alexander, et al.
Publicado: (2022)

Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)

Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists
por: Wolfe, Kate, et al.
Publicado: (2017)

Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case–control study
por: Sun, James J., et al.
Publicado: (2023)

Prescribing practices in the treatment of depression among psychiatrists in Oman
por: Albalushi, Marwa A., et al.
Publicado: (2021)

Impact on psychiatrists in intellectual disability of Court of Protection orders for section 49 (Mental Capacity Act) reports: online survey
por: Perera, Suraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d4gi25d3hbim4o422mvb0kq0ro